Filters close
10-Nov-2020 12:05 PM EST
Unique Coagulation Driven by IL-6 Trans-Signaling Associated with Liver Injury in COVID-19
American Association for the Study of Liver Diseases (AASLD)

ALEXANDRIA, VA – Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that COVID-19 coagulation impairment, driven in part by endothelial Factor VIII, is associated with liver injury in infected patients. The study’s findings also show that IL-6 trans-signaling, which may play a role in COVID-19 development, results in prothrombotic liver sinusoidal endothelial cells (LSECs) that may mediate the liver injury via elevated Factor VIII and activation of coagulation in the liver microvasculature.

10-Nov-2020 12:05 PM EST
New Machine Learning-Based Model More Accurately Predicts Liver Transplant Waitlist Mortality
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that using neural networks, a type of machine learning algorithm, is a more accurate model for predicting waitlist mortality in liver transplantation, outperforming the older model for end-stage liver disease (MELD) scoring. This advancement could lead to the development of more equitable organ allocation systems and even reduce liver transplant waitlist death rates for patients.

10-Nov-2020 12:05 PM EST
Alarming New Study Highlights Need for Improved Access to HBV Vaccination, Testing and Treatment
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that in 2019, more than 500,000 persons died of hepatitis B virus infection, highlighting the urgent need for universal HBV vaccination of children beginning at birth, and scaling up testing and access to care and treatment before people with the virus develop life-threatening liver cirrhosis or liver cancer.

10-Nov-2020 12:05 PM EST
Improved Center-Specific Practices May Ease Effects of Socioeconomic Deprivation for Pediatric Liver Transplant Recipients
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that while neighborhood socioeconomic deprivation is associated with worse adverse long-term outcomes after liver transplant in children, improving center-specific practices can mitigate these effects for young at-risk patients.

27-Jul-2020 4:00 PM EDT
American Association for the Study of Liver Diseases Foundation Announces Funding of over $2.2 Million in Research and Career Development Awards, Abstract Awards, and Emerging Liver Scholars Program
American Association for the Study of Liver Diseases (AASLD)

The American Association for the Study of Liver Diseases (AASLD) Foundation, the largest private supporter of liver disease research and training in the United States, today announced its combined investment of over $2.2 million in Research and Career Development Awards, Abstract Awards, and its Emerging Liver Scholars (ELS) Program.

Released: 25-Mar-2020 1:15 PM EDT
AASLD Releases Clinical Insight Guide for Treating Patients with Liver Disease and COVID-19
American Association for the Study of Liver Diseases (AASLD)

The American Association for the Study of Liver Disease (AASLD) has released a clinical insight document for clinicians and frontline healthcare providers who are treating patients with liver disease during the COVID-19 pandemic. The document, which cites recent studies conducted in China, assesses how hepatologists and liver transplant physicians/surgeons and their patients may be affected by the COVID-19 virus (also known as SARS-CoV-2) and provides continued guidance on clinical approaches to disease management.

Released: 3-Dec-2019 3:40 PM EST
HCV Guidance Updates Recommendations for Identification and Management of Chronic Hep C
American Association for the Study of Liver Diseases (AASLD)

HCVguidelines.org — a website developed by the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America to provide up-to-date guidance on the management of hepatitis C — was recently revised to reflect important developments in the identification and management of chronic hepatitis C (HCV)

Released: 20-Nov-2019 3:30 PM EST
Matthew R. D’Uva to Join AASLD as CEO
American Association for the Study of Liver Diseases (AASLD)

The American Association for the Study of Liver Diseases (AASLD) has appointed Matthew R. D’Uva, FASAE, CAE, as its new chief executive officer, effective January 21, 2020.

4-Nov-2019 8:00 AM EST
Kratom, Botanical Supplement with Opioid-Like Activity, May Cause Liver Toxicity and Injury
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that kratom, a popular and widely available product, may cause liver toxicity and severe liver injury.

4-Nov-2019 8:00 AM EST
Sexual Transmission of Hepatitis C Low Among HIV-Negative Men Who Have Sex with Men on PrEP
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found fewer new cases of hepatitis C infection (commonly called HCV), despite very high rates of other sexually-transmitted infections, in HIV-negative men who have sex with men who take pre-exposure prophylaxis (PrEP) treatments.

4-Nov-2019 8:00 AM EST
U.S. Cirrhosis Patients Often Skip or Delay Liver Cancer Surveillance Due to Cost and Lack of Insurance
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that cirrhosis patients in the U.S. have substantial financial burden

4-Nov-2019 8:00 AM EST
Global Hepatology Societies Call for Better HCV Testing and Access to Treatment
American Association for the Study of Liver Diseases (AASLD)

Four societies focused on liver disease research and treatment announced a global call-to-action initiative to simplify hepatitis C testing and treatment.

4-Nov-2019 8:00 AM EST
A Healthy Lifestyle May Help Prevent Liver-Related Deaths
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that a substantial burden of hepatocellular carcinoma (HCC) and cirrhosis-related deaths may be prevented by lifestyle modifications to diet, alcohol use and exercise.

4-Nov-2019 8:00 AM EST
All-Oral Direct-Acting Antiviral Treatments Improve Survival in Patients with HCV-Related Hepatocellular Carcinoma
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that hepatitis C virus-related hepatocellular carcinoma (HCC) patients who achieved sustained virologic response (SVR) – denoting an undetectable level of HCV virus - with any oral direct-acting antiviral (DAA) had over 60-70 percent improvement in five-year survival.

4-Nov-2019 8:00 AM EST
NAFLD Patients Less Likely to Lose Weight, Need More Effective Weight Loss Strategies
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that obese individuals with nonalcoholic fatty liver disease (NAFLD) were less likely to achieve a medically recommended five percent loss of body weight at three months

4-Nov-2019 8:00 AM EST
Innovative Machine Learning Tool Predicts Who Might Have Non-Alcoholic Steatohepatitis
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that a machine-learning tool could successfully predict the risk of having non-alcoholic steatohepatitis (NASH) among patients with co-existing diseases.

4-Nov-2019 8:00 AM EST
Pregnant Women With Cirrhosis Have Low Levels of Liver Decompensation Within a Year of Delivery
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases and funded by the AASLD Foundation

4-Nov-2019 8:00 AM EST
Could Combining Direct-Acting Antivirals with a Common Cholesterol Medication Open the Door to More Viable Organs for Transplantation?
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that combination therapy with direct-acting antivirals (DAAs) and ezetimibe

Released: 24-Jun-2019 4:30 PM EDT
AASLD Foundation Invests $3.42 Million in Liver Disease Research and Career Development
American Association for the Study of Liver Diseases (AASLD)

The American Association for the Study of Liver Diseases Foundation, the largest private supporter of liver disease research and training in the United States, today announced its investment of $3.42 million in Research and Career Development Awards granted to 29 researchers and clinicians to conduct innovative liver disease research and seek advanced hepatology training.



close
0.14662